Skip to main content

1 Result(s)

within Jiao Mu Remove this filter English Remove this filter Hematology Remove this filter Human Genetics Remove this filter

and

  1. No Access

    Article

    Efficacy of Flumatinib in CML Patients with F359V/C Mutation

    The BCR-ABL mutation is the main cause of tyrosine kinase inhibitors(TKI) resistance. The second-generation TKI can overcome most of the mutations. However, both dasatinib and nilotinib have a unique set of mu...

    Hua Gao, Libo Li, Jiao Mu, **g Tan… in Indian Journal of Hematology and Blood Tra… (2023)